SLC2A1 and neoplasm: The tumor expressions of GLUT-1, Cyclin D1, TGF-α, VEGF, and EPO are specific targets of HIF-2a in chronic hypoxia when an oxidative phenotype is induced and even when tumor aggressivity and treatment resistance are high [40,45,46,47,48,49,50].